way 100135 has been researched along with cholecystokinin in 2 studies
| Studies (way 100135) | Trials (way 100135) | Recent Studies (post-2010) (way 100135) | Studies (cholecystokinin) | Trials (cholecystokinin) | Recent Studies (post-2010) (cholecystokinin) |
|---|---|---|---|---|---|
| 143 | 0 | 34 | 10,914 | 466 | 1,074 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fink, H; Marsden, CA; Voigt, JP | 1 |
| Bickerdike, MJ; Fletcher, A; Marsden, CA | 1 |
2 other study(ies) available for way 100135 and cholecystokinin
| Article | Year |
|---|---|
Evidence for the involvement of the 5-HT1A receptor in CCK induced satiety in rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Cholecystokinin; Eating; Male; Piperazines; Rats; Rats, Wistar; Receptors, Serotonin; Satiety Response; Serotonin Antagonists; Serotonin Receptor Agonists | 1995 |
Attenuation of CCK-induced aversion in rats on the elevated x-maze by the selective 5-HT1A receptor antagonists (+) WAY100135 and WAY100635.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anxiety; Behavior, Animal; Cholecystokinin; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Maze Learning; Peptide Fragments; Piperazines; Pyridines; Rats; Rats, Inbred Strains; Serotonin Antagonists; Sincalide; Time Factors | 1995 |